Advertisement
Screener

BEONE MEDICINES LTD. (BEIGF) Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture

2.8 / 5 stars · 68/120 Roast Me

BEONE MEDICINES LTD. Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture

BEONE MEDICINES LTD. (BEIGF) reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $80.76 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.

Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement

us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2025-11-06

  • BEONE MEDICINES LTD. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-09-30 was $80.76M, a 313.69% increase year-over-year.
  • BEONE MEDICINES LTD. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-06-30 was $32.73M, a 628.70% increase year-over-year.
  • BEONE MEDICINES LTD. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2025-03-31 was $63.88M, a 307.81% increase year-over-year.
  • BEONE MEDICINES LTD. shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2024-09-30 was $19.52M.
Period endShares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 monthShares Granted, Value, Share-based Payment Arrangement, after Forfeiture 6 monthShares Granted, Value, Share-based Payment Arrangement, after Forfeiture 9 month
2025-09-30$80.76M
10-Q · filed 2025-11-06
$113.49M
derived: sum of 2 quarters · filed 2025-11-06
$177.37M
derived: sum of 3 quarters · filed 2025-11-06
2025-06-30$32.73M
10-Q · filed 2025-11-06
$96.61M
derived: sum of 2 quarters · filed 2025-11-06
2025-03-31$63.88M
10-Q · filed 2025-11-06
2024-09-30$19.52M
10-Q · filed 2025-11-06
$24.01M
derived: sum of 2 quarters · filed 2025-11-06
$39.68M
derived: sum of 3 quarters · filed 2025-11-06
2024-06-30$4.49M
10-Q · filed 2025-11-06
$20.16M
derived: sum of 2 quarters · filed 2025-11-06
2024-03-31$15.66M
10-Q · filed 2025-11-06